aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
aTYR PHARMA reports 2023 executive compensation
By ExecPay News
Published: April 5, 2024
aTYR PHARMA reported fiscal year 2023 executive compensation information on April 5, 2024.
In 2023, three executives at aTYR PHARMA received on average a compensation package of $877K, a 37% decrease compared to previous year.
Average pay of disclosed executives at aTYR PHARMA
Sanjay S. Shukla, Chief Executive Officer, received $1.3M in total, which decreased by 46% compared to 2022. 43% of Shukla's compensation, or $561K, was in salary. Shukla also received $196K in non-equity incentive plan, $532K in option awards, as well as $11K in other compensation.
Jill M. Broadfoot, Chief Financial Officer, received a compensation package of $678K, which decreased by 26% compared to previous year. 61% of the compensation package, or $414K, was in salary.
Nancy E. Denyes, General Counsel, earned $651K in 2023, a 24% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 5, 2024.